Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34


Kras/ADAM17-dependent Jag1-ICD reverse signalling sustains colorectal cancer progression and chemoresistance.

Pelullo M, Nardozza F, Zema S, Quaranta R, Nicoletti C, Besharat ZM, Felli MP, Cerbelli B, d'Amati G, Palermo R, Capalbo C, Talora C, Di Marcotullio L, Giannini G, Checquolo S, Screpanti I, Bellavia D.

Cancer Res. 2019 Sep 10. pii: canres.0145.2019. doi: 10.1158/0008-5472.CAN-19-0145. [Epub ahead of print]


Notch/CXCR4 Partnership in Acute Lymphoblastic Leukemia Progression.

Tsaouli G, Ferretti E, Bellavia D, Vacca A, Felli MP.

J Immunol Res. 2019 Jun 27;2019:5601396. doi: 10.1155/2019/5601396. eCollection 2019. Review.


Histone Modifications Drive Aberrant Notch3 Expression/Activity and Growth in T-ALL.

Tottone L, Zhdanovskaya N, Carmona Pestaña Á, Zampieri M, Simeoni F, Lazzari S, Ruocco V, Pelullo M, Caiafa P, Felli MP, Checquolo S, Bellavia D, Talora C, Screpanti I, Palermo R.

Front Oncol. 2019 Apr 3;9:198. doi: 10.3389/fonc.2019.00198. eCollection 2019.


Notch and NF-κB: Coach and Players of Regulatory T-Cell Response in Cancer.

Ferrandino F, Grazioli P, Bellavia D, Campese AF, Screpanti I, Felli MP.

Front Immunol. 2018 Oct 11;9:2165. doi: 10.3389/fimmu.2018.02165. eCollection 2018. Review.


Intrathymic Notch3 and CXCR4 combinatorial interplay facilitates T-cell leukemia propagation.

Ferrandino F, Bernardini G, Tsaouli G, Grazioli P, Campese AF, Noce C, Ciuffetta A, Vacca A, Besharat ZM, Bellavia D, Screpanti I, Felli MP.

Oncogene. 2018 Dec;37(49):6285-6298. doi: 10.1038/s41388-018-0401-2. Epub 2018 Jul 23.


Notch signaling as a therapeutic target for acute lymphoblastic leukemia.

Bellavia D, Palermo R, Felli MP, Screpanti I, Checquolo S.

Expert Opin Ther Targets. 2018 Apr;22(4):331-342. doi: 10.1080/14728222.2018.1451840. Epub 2018 Mar 21. Review.


Maml1 acts cooperatively with Gli proteins to regulate sonic hedgehog signaling pathway.

Quaranta R, Pelullo M, Zema S, Nardozza F, Checquolo S, Lauer DM, Bufalieri F, Palermo R, Felli MP, Vacca A, Talora C, Di Marcotullio L, Screpanti I, Bellavia D.

Cell Death Dis. 2017 Jul 20;8(7):e2942. doi: 10.1038/cddis.2017.326.


The mazy case of Notch and immunoregulatory cells.

Grazioli P, Felli MP, Screpanti I, Campese AF.

J Leukoc Biol. 2017 Aug;102(2):361-368. doi: 10.1189/jlb.1VMR1216-505R. Epub 2017 Mar 14. Review.


Multidrug Resistance Protein-4 Influences Aspirin Toxicity in Human Cell Line.

Massimi I, Ciuffetta A, Temperilli F, Ferrandino F, Zicari A, Pulcinelli FM, Felli MP.

Mediators Inflamm. 2015;2015:607957. doi: 10.1155/2015/607957. Epub 2015 Sep 27.


Notch3/Jagged1 circuitry reinforces notch signaling and sustains T-ALL.

Pelullo M, Quaranta R, Talora C, Checquolo S, Cialfi S, Felli MP, te Kronnie G, Borga C, Besharat ZM, Palermo R, Di Marcotullio L, Capobianco AJ, Gulino A, Screpanti I, Bellavia D.

Neoplasia. 2014 Dec;16(12):1007-17. doi: 10.1016/j.neo.2014.10.004.


Aspirin extrusion from human platelets through multidrug resistance protein-4-mediated transport: evidence of a reduced drug action in patients after coronary artery bypass grafting.

Mattiello T, Guerriero R, Lotti LV, Trifirò E, Felli MP, Barbarulo A, Pucci B, Gazzaniga P, Gaudio C, Frati L, Pulcinelli FM.

J Am Coll Cardiol. 2011 Aug 9;58(7):752-61. doi: 10.1016/j.jacc.2011.03.049. Erratum in: J Am Coll Cardiol. 2011 Oct 18;58(17):1832.


Notch3 and canonical NF-kappaB signaling pathways cooperatively regulate Foxp3 transcription.

Barbarulo A, Grazioli P, Campese AF, Bellavia D, Di Mario G, Pelullo M, Ciuffetta A, Colantoni S, Vacca A, Frati L, Gulino A, Felli MP, Screpanti I.

J Immunol. 2011 Jun 1;186(11):6199-206. doi: 10.4049/jimmunol.1002136. Epub 2011 Apr 20.


Notch3: from subtle structural differences to functional diversity.

Bellavia D, Checquolo S, Campese AF, Felli MP, Gulino A, Screpanti I.

Oncogene. 2008 Sep 1;27(38):5092-8. doi: 10.1038/onc.2008.230. Review.


Notch signaling and diseases: an evolutionary journey from a simple beginning to complex outcomes.

Talora C, Campese AF, Bellavia D, Felli MP, Vacca A, Gulino A, Screpanti I.

Biochim Biophys Acta. 2008 Sep;1782(9):489-97. doi: 10.1016/j.bbadis.2008.06.008. Epub 2008 Jun 24. Review.


Notch3 and pre-TCR interaction unveils distinct NF-kappaB pathways in T-cell development and leukemia.

Vacca A, Felli MP, Palermo R, Di Mario G, Calce A, Di Giovine M, Frati L, Gulino A, Screpanti I.

EMBO J. 2006 Mar 8;25(5):1000-8. Epub 2006 Feb 23.


PKC theta mediates pre-TCR signaling and contributes to Notch3-induced T-cell leukemia.

Felli MP, Vacca A, Calce A, Bellavia D, Campese AF, Grillo R, Di Giovine M, Checquolo S, Talora C, Palermo R, Di Mario G, Frati L, Gulino A, Screpanti I.

Oncogene. 2005 Feb 3;24(6):992-1000.


The thymus at the crossroad of neuroimmune interactions.

Maroder M, Bellavia D, Vacca A, Felli MP, Screpanti I.

Ann N Y Acad Sci. 2000;917:741-7. Review.


Expression of metabotropic glutamate receptors in murine thymocytes and thymic stromal cells.

Storto M, de Grazia U, Battaglia G, Felli MP, Maroder M, Gulino A, Ragona G, Nicoletti F, Screpanti I, Frati L, Calogero A.

J Neuroimmunol. 2000 Sep 22;109(2):112-20.


Constitutive activation of NF-kappaB and T-cell leukemia/lymphoma in Notch3 transgenic mice.

Bellavia D, Campese AF, Alesse E, Vacca A, Felli MP, Balestri A, Stoppacciaro A, Tiveron C, Tatangelo L, Giovarelli M, Gaetano C, Ruco L, Hoffman ES, Hayday AC, Lendahl U, Frati L, Gulino A, Screpanti I.

EMBO J. 2000 Jul 3;19(13):3337-48.


Identification of an estrogen-mediated deoxyribonucleic acid-binding independent transactivation pathway on the epidermal growth factor receptor gene promoter.

Salvatori L, Ravenna L, Felli MP, Cardillo MR, Russo MA, Frati L, Gulino A, Petrangeli E.

Endocrinology. 2000 Jun;141(6):2266-74.


Expression pattern of notch1, 2 and 3 and Jagged1 and 2 in lymphoid and stromal thymus components: distinct ligand-receptor interactions in intrathymic T cell development.

Felli MP, Maroder M, Mitsiadis TA, Campese AF, Bellavia D, Vacca A, Mann RS, Frati L, Lendahl U, Gulino A, Screpanti I.

Int Immunol. 1999 Jul;11(7):1017-25.


Prostaglandin E2 inhibits the interleukin-2 promoter activity through down-regulation of the Oct-dependent transcription of the octamer motif.

Felli MP, Moschella C, Farina AR, Alesse E, Screpanti I, Teti D, Frati L, Gulino A.

Cell Immunol. 1996 Sep 15;172(2):229-34.


Androgenic and antiandrogenic control on epidermal growth factor, epidermal growth factor receptor, and androgen receptor expression in human prostate cancer cell line LNCaP.

Ravenna L, Lubrano C, Di Silverio F, Vacca A, Felli MP, Maroder M, D'Eramo G, Sciarra F, Frati L, Gulino A, et al.

Prostate. 1995 Jun;26(6):290-8.


Positive and negative regulation of the composite octamer motif of the interleukin 2 enhancer by AP-1, Oct-2, and retinoic acid receptor.

de Grazia U, Felli MP, Vacca A, Farina AR, Maroder M, Cappabianca L, Meco D, Farina M, Screpanti I, Frati L, Gulino A.

J Exp Med. 1994 Oct 1;180(4):1485-97.


Cell-specific bifunctional role of Jun oncogene family members on glucocorticoid receptor-dependent transcription.

Maroder M, Farina AR, Vacca A, Felli MP, Meco D, Screpanti I, Frati L, Gulino A.

Mol Endocrinol. 1993 Apr;7(4):570-84.


Glucocorticoid receptor-mediated suppression of the interleukin 2 gene expression through impairment of the cooperativity between nuclear factor of activated T cells and AP-1 enhancer elements.

Vacca A, Felli MP, Farina AR, Martinotti S, Maroder M, Screpanti I, Meco D, Petrangeli E, Frati L, Gulino A.

J Exp Med. 1992 Mar 1;175(3):637-46.


Inheritance of ribosomal gene activity and level of DNA methylation of individual gene clusters in a three generation family.

de Capoa A, Aleixandre C, Felli MP, Ravenna L, Costantino MA, Giancotti P, Vicenti O, Poggesi I, Grappelli C, Miller DA.

Hum Genet. 1991 Dec;88(2):146-52.


Retinoic acid-induced down-regulation of the interleukin-2 promoter via cis-regulatory sequences containing an octamer motif.

Felli MP, Vacca A, Meco D, Screpanti I, Farina AR, Maroder M, Martinotti S, Petrangeli E, Frati L, Gulino A.

Mol Cell Biol. 1991 Sep;11(9):4771-8.


Enhancement of natural-killer-cell susceptibility of human breast-cancer cells by estradiol and v-Ha-ras oncogene.

Screpanti I, Felli MP, Toniato E, Meco D, Martinotti S, Frati L, Santoni A, Gulino A.

Int J Cancer. 1991 Feb 1;47(3):445-9.


Transcriptional regulation of the interleukin 2 gene by glucocorticoid hormones. Role of steroid receptor and antigen-responsive 5'-flanking sequences.

Vacca A, Martinotti S, Screpanti I, Maroder M, Felli MP, Farina AR, Gismondi A, Santoni A, Frati L, Gulino A.

J Biol Chem. 1990 May 15;265(14):8075-80.


Relationship between the number and function of human ribosomal genes.

de Capoa A, Felli MP, Baldini A, Rocchi M, Archidiacono N, Aleixandre C, Miller OJ, Miller DA.

Hum Genet. 1988 Aug;79(4):301-4.


Laron dwarfism: cellular unresponsiveness to GH demonstrated on cultured lymphocytes by a cytochemical method.

Spadoni GL, Cianfarani S, Baldini A, Ravenna L, Felli MP, Camaioni A, Manca Bitti ML, Sciré G, Boscherini B, de Capoa A.

Horm Metab Res. 1988 Jul;20(7):450-2.


Differential ribosomal gene responsiveness to human growth hormone is visualized by selective silver staining.

Baldini A, Felli MP, Ravenna L, Camaioni A, de Capoa A, Spadoni GL, Cianfarani S, Boscherini B.

Cytogenet Cell Genet. 1988;47(1-2):22-5.


Growth hormone-induced regulation of rRNA gene activity in human cultured cells.

de Capoa A, Marlekaj P, Baldini A, Felli MP, Rocchi M, Archidiacono N, Cianfarani S, Spadoni GL, Boscherini B.

Horm Metab Res. 1986 Aug;18(8):574-5. No abstract available.


Supplemental Content

Loading ...
Support Center